Dorothy Margolskee

Background

Dorothy Margolskee is a Managing Director at Foresite Capital who joined the firm in 2012. She built the investment technical review process at Foresite, rigorously analyzing biotech portfolios on scientific validation and regulatory risk. Previously she spent 15 years at Merck Research Labs, rising to Senior Vice President, and was deeply involved in vaccine programs including Gardasil, RotaTeq, and Varivax. She holds an MD from Johns Hopkins Medical School (Alpha Omega Alpha) and a BA from Harvard University, graduating summa cum laude.

Investment Focus